Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Double-masked, Sham Controlled, Dose-ranging Study to Evaluate the Safety and Effectiveness of Low Voltage Stereotactic Radiosurgery in Patients With Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration (AMD)

NCT01016873 is registered in ClinicalTrials.gov with Oraya Therapeutics, Inc. as lead sponsor.

NCT NCT01016873
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01016873 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Double-masked, Sham Controlled, Dose-ranging Study to Evaluate the Safety and Effectiveness of Low Voltage Stereotactic Radiosurgery in Patients With Choroidal Neovascularization (CNV) Secondary to Age-related Macular Degeneration (AMD)
Lead sponsor
Oraya Therapeutics, Inc.
Phase
Phase 2
Overall status
Completed
Start date
November 30, 2009
Completion date
April 30, 2014
Enrollment
230 (actual)
Sites
21

Conditions

As the registry lists them; a condition with its own page is linked.

age-related macular degeneration, amd, eye diseases, macular degeneration, retinal diseases, wet age-related macular degeneration, wet amd